Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jazz Pharmaceuticals plc(JAZZ) | 167,816 | 167,816 | 0 | $40.4K | $38.9K | 14.64% | -$1.6K |
| Enanta Pharmaceuticals Inc | 2,866,138 | 2,866,138 | 0 | $41.8K | $37.8K | 14.23% | -$4.0K |
| United Therapeutics Corporation(UTHR) | 69,282 | 66,282 | -3,000 | $37.5K | $35.9K | 13.53% | -$1.6K |
| BioMarin Pharmaceutical Inc.(BMRN) | 524,786 | 524,786 | 0 | $30.0K | $31.5K | 11.86% | +$1.5K |
| Abbott Laboratories | 200,000 | 200,000 | 0 | $18.1K | $19.8K | 7.45% | +$1.6K |
| Exelixis, Inc.(EXEL) | 370,693 | 299,393 | -71,300 | $20.2K | $17.5K | 6.59% | -$2.7K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 390,879 | 1,140,867 | +749,988 | $13.1K | $17.1K | 6.46% | +$4.1K |
| Supernus Pharmaceuticals Inc | 280,681 | 350,681 | +70,000 | $13.1K | $15.1K | 5.69% | +$2.0K |
| Sanofi(SNY) | 323,946 | 333,946 | +10,000 | $13.8K | $13.8K | 5.19% | -$51 |
| Embecta Corp | 1,135,340 | 1,135,340 | 0 | $3.7K | $6.4K | 2.42% | +$2.7K |
| Ardelyx Inc | 534,523 | 1,815,492 | +1,280,969 | $2.7K | $6.2K | 2.34% | +$3.5K |
| BioNTech SE(BNTX) | 59,523 | 59,523 | 0 | $5.5K | $5.9K | 2.20% | +$312 |
| Vanda Pharmaceuticals Inc | 1,180,388 | 1,180,388 | 0 | $7.2K | $5.8K | 2.18% | -$1.4K |
| GSK plc(GSK) | 96,729 | 96,729 | 0 | $5.1K | $4.7K | 1.76% | -$412 |
| Biogen Inc.(BIIB) | 20,000 | 20,000 | 0 | $4.3K | $4.5K | 1.70% | +$197 |
| Inmode Ltd | 120,942 | 120,942 | 0 | $1.8K | $1.7K | 0.65% | -$54 |
| ANI Pharmaceuticals, Inc.(ANIP) | 0 | 13,000 | +13,000 | $0 | $944 | 0.36% | +$944 |
| Acadia Pharmaceuticals Inc | 0 | 40,000 | +40,000 | $0 | $806 | 0.30% | +$806 |
| Zoetis Inc.(ZTS) | 0 | 10,000 | +10,000 | $0 | $698 | 0.26% | +$698 |
| Evolus Inc | 157,985 | 57,985 | -100,000 | $1.1K | $464 | 0.17% | -$632 |
| Regeneron Pharmaceuticals, Inc.(REGN) | 6,000 | 0 | -6,000 | $3.7K | $0 | — | -$3.7K |